MedPath
HSA Approval

TemoRel HARD CAPSULE 100MG

SIN15709P

TemoRel HARD CAPSULE 100MG

TemoRel HARD CAPSULE 100MG

June 10, 2019

WELLCHEM PHARMACEUTICALS PTE LTD

WELLCHEM PHARMACEUTICALS PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantWELLCHEM PHARMACEUTICALS PTE LTD
Licence HolderWELLCHEM PHARMACEUTICALS PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

L01AX03

temozolomide

Manufacturer Information

WELLCHEM PHARMACEUTICALS PTE LTD

Reliance Life Sciences Pvt Ltd.

Active Ingredients

Temozolomide

100mg

Temozolomide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TemoRel HARD CAPSULE 100MG - HSA Approval | MedPath